Gilead Sciences Total Depreciation and Amortization - Cash Flow 2010-2025 | GILD

Gilead Sciences total depreciation and amortization - cash flow for the twelve months ending March 31, 2025 was $6.921B, a 3.16% increase year-over-year.

  • Gilead Sciences annual total depreciation and amortization - cash flow for 2024 was $2.767B, a 2.75% increase from 2023.
  • Gilead Sciences annual total depreciation and amortization - cash flow for 2023 was $2.693B, a 28.06% increase from 2022.
  • Gilead Sciences annual total depreciation and amortization - cash flow for 2022 was $2.103B, a 2.59% increase from 2021.

Gilead Sciences Total Depreciation and Amortization - Cash Flow 2010-2025 | GILD

  • Gilead Sciences annual total depreciation and amortization - cash flow for 2024 was $2.767B, a 2.75% increase from 2023.
  • Gilead Sciences annual total depreciation and amortization - cash flow for 2023 was $2.693B, a 28.06% increase from 2022.
  • Gilead Sciences annual total depreciation and amortization - cash flow for 2022 was $2.103B, a 2.59% increase from 2021.